Разработка вакцин для профилактики коронавирусной инфекции: от SARS и MERS до COVID-19

ЙД Ли, ВЮ Чи, ЦХ Су, Л Ферралл, ЧФ Хун, ЦЧ Ву - Juvenis scientia, 2020 - jscientia.org
Аннотация Коронавирус тяжелого острого респираторного синдрома (SARS-CoV-2)–
это новый вид коронавируса, вызывающий коронавирусную инфекцию 2019 года …

[PDF][PDF] Baymiev An. Kh., Maksimov IV, Kuluev BR, Baymiev Al. Kh., Chemeris AV Human betacoronaviruses and their highly sensitive detection by PCR and other …

RR Garafutdinov, AR Mavzyutov, I Alekseev Ya… - 2020 - biomicsj.ru
This review focuses primarily on betacoronavirus SARS-CoV-2, which caused a pandemic
in early 2020 in the form of a dangerous highly contagious coronavirus infection COVID-19 …

Developing Vaccine Against COVID-19 and Immune Response

U Jarouliya, RK Keservani - COVID-19 and Immunomodulation …, 2023 - taylorfrancis.com
Coronavirus disease infected the entire world and is usually named as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 …

Бетакоронавирусы человека и их высокочувствительная детекция с помощью ПЦР и прочих методов амплификации

РР Гарафутдинов, АР Мавзютов, ЯИ Алексеев… - Биомика, 2020 - elibrary.ru
Данный обзор посвящен преимущественно бетакоронавирусу SARS-CoV-2,
вызвавшему в начале 2020 г. пандемию в виде опасной высококонтагиозной …

Qualitative and quantitative determination of MERS-CoV S1-specific antibodies using ELISA

SS Al-Amri, AM Hashem - MERS Coronavirus: Methods and Protocols, 2020 - Springer
Indirect enzyme-linked immunosorbent assay (ELISA) enables detection and quantification
of antigen-specific antibodies in biological samples such as human or animal sera. Most …

Assessment of the immunogenicity and protective aspects of a DNA vaccine targeting Crimean Congo hemorrhagic fever virus glycoprotein Gc

E Sahin, AÇ Cihan, T Aligholipour, K Foldes… - Duzce Medical …, 2021 - dergipark.org.tr
Aim: Crimean Congo Hemorrhagic Fever (CCHF) is a lethal, endemic infectious disease in
human. For the preventive measures of the disease, there is currently no safe and efficient …

Immunopathogenesis and perspectives for immunotherapy of coronavirus infection

A Simbirtsev - 2021 - covid19.neicon.ru
Highly pathogenic coronavirus SARS-CoV-2 is the cause of COVID-19 in humans
sometimes with severe clinical manifestations and death. COVID-19 immunopathogenesis is …

Coronavirus vaccine

U Sahin, A Güler, A Kuhn, A Muik, A Vogel… - US Patent …, 2023 - Google Patents
2022-05-13 Assigned to BioNTech SE reassignment BioNTech SE ASSIGNMENT OF
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SAHIN, UGUR …

Coronavirus vaccine

U Sahin, A Güler, A Kuhn, A Muik, A Vogel… - US Patent …, 2024 - Google Patents
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-
amino-3-phenylpropanoyl] amino]-3-phenylpropanoyl] amino]-4-methylpentanoyl] amino] …

The possible role of novel coronavirus 2019 proteins in the development of drugs and vaccines

HEG Ghaleh, MR Karimi, P Rezayat… - Journal of Applied …, 2020 - eprints.bmsu.ac.ir
While the world has faced an epidemic disease resulted from severe acute respiratory
syndrome coronavirus (SARS-CoV), a disease which has derived from a new coronavirus …